ICN Statement about falsified medicines at WHO 144th Executive Board

The ICN is particularly emphasized the need to see the issue of falsified medicines as ‘a symptom of a larger problem’, namely a lack of access to high-quality, affordable and effective healthcare. The Council is encouraging the Member State Mechanism to engage with our campaign and to foster collaborative action with important stakeholders in the fight against fake medicines.